| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC1637 |
| Trial ID | NCT02869217 |
| Disease | Esophageal Cancer | Melanoma | Synovial Sarcoma | Lung Cancer | Liver Cancer | Ovarian Cancer | Bladder Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TBI-1301 |
| HLA | HLA-A*02:01|HLA-A*02:06 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors |
| Year | 2016 |
| Country | Canada |
| Company sponsor | University Health Network, Toronto |
| Other ID(s) | 1301-02 |
| Cohort 1 | |||||||||
|
|||||||||